The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation
Publication
, Conference
Yan, X; Peters, G; Sharma, A; Nandy, P; Nessel, C; Garmann, D; Willmann, S; Hermanowski-Vosatka, A; Solms, A; Berkowitz, SD; Spiro, TE ...
Published in: BLOOD
December 7, 2017
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 7, 2017
Volume
130
Location
Atlanta, GA
Publisher
AMER SOC HEMATOLOGY
Conference Name
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Yan, X., Peters, G., Sharma, A., Nandy, P., Nessel, C., Garmann, D., … Zhang, L. (2017). The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation. In BLOOD (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.
Yan, Xiaoyu, Gary Peters, Amarnath Sharma, Partha Nandy, Christopher Nessel, Dirk Garmann, Stefan Willmann, et al. “The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation.” In BLOOD, Vol. 130. AMER SOC HEMATOLOGY, 2017.
Yan X, Peters G, Sharma A, Nandy P, Nessel C, Garmann D, et al. The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation. In: BLOOD. AMER SOC HEMATOLOGY; 2017.
Yan, Xiaoyu, et al. “The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation.” BLOOD, vol. 130, AMER SOC HEMATOLOGY, 2017.
Yan X, Peters G, Sharma A, Nandy P, Nessel C, Garmann D, Willmann S, Hermanowski-Vosatka A, Solms A, Berkowitz SD, Spiro TE, Fox KAA, Weitz JI, Schmidt S, Piccini JP, Patel M, Becker RC, Zhang L. The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation. BLOOD. AMER SOC HEMATOLOGY; 2017.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 7, 2017
Volume
130
Location
Atlanta, GA
Publisher
AMER SOC HEMATOLOGY
Conference Name
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology